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Abstract
Purpose Cystic fibrosis (CF) is a multisystem genetic disease caused by dysfunction of the epithelial anionic channel Cystic 
Fibrosis Transmembrane conductance Regulator (CFTR). Decreased mucociliary clearance because of thickened mucus is 
part of the pulmonary disease pathophysiology. It is controversial if the thickened airway surface liquid (ASL) is caused by 
the deficient chloride secretion and excessive sodium (through ENaC) and water hyperabsorption from the periciliar fluid 
or by the lack of bicarbonate secretion with relative acidification of the ASL. Correlations between the magnitude of in vivo 
chloride conductance with phenotypic characteristics and CF genotype can help to elucidate these mechanisms and direct 
to new treatments.
Methods Nasal potential difference was measured in 28 CF patients (age from 0.3 to 28 year) and correlated with pulmonary 
function, pancreatic phenotype, pulmonary colonization and genotype severity.
Results The CFTR-chloride conductance was better in older patients (r = 0.40; P = 0.03), in patients with better pulmonary 
function (r = 0.48; P = 0.01), and was associated with genotype severity. Higher chloride diffusion in the presence of a 
favorable chemical gradient was associated with Pseudomonas aeruginosa negativity (P < 0.05). More negative NPDmax 
was associated with pancreatic insufficiency (P < 0.01) as well with genotype severity, but not with the pulmonary function.
Conclusions The anion permeability through CFTR, mainly chloride, but bicarbonate as well, is the most critical factor in CF 
airway pathophysiology. Treatments primarily directed to correct CFTR function and/or airway acidity are clearly a priority.
Keywords Cystic fibrosis · Genetic disease · CFTR · Bicarbonate · Pseudomonas aeruginosa
Introduction
Cystic fibrosis (CF) is a recessive genetic disease caused 
by CF transmembrane conductance regulator (CFTR) gene 
mutations that encodes the CFTR protein [1]. CFTR protein 
is an epithelial ion channel that transports chloride  (Cl−) 
and bicarbonate  (HCO3−), and regulates other ion channels 
(namely sodium, potassium, other chloride and calcium 
channels). It also interacts with other membrane proteins to 
maintain epithelial tight-junctions and barriers to fluid flow. 
CFTR protein adjusts the levels of acidity in secretions that, 
along with fluid and chloride abnormalities, lead to some 
of the common manifestations of the CF clinical syndrome 
such as small airway disease and pancreatic insufficiency 
[2]. The disrupted ion transport also causes cell hyperpo-
larization or depolarization depending on whether the cell 
is secretory or absorptive, respectively [3].
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Impairment of the mucociliary clearance (MCC) because 
of increased viscosity of the airway surface liquid (ASL) is 
thought to predispose CF patients to small airway disease 
with chronic airway infection, associated airway inflamma-
tion, progressive airway obstruction and lung injury [3–6]. 
How the dysfunctional CFTR leads to increased viscosity of 
ASL remains somewhat controversial since some researches 
hold that it is caused by deficient chloride secretion and 
excessive sodium and water reabsorption from the pericil-
iar fluid [6] while other hold that it is caused by a lack of 
bicarbonate secretion with relative acidification of airway 
surface liquids [4].
Nasal potential difference (NPD) estimates the rela-
tive ion conductance based on transepithelial voltage (Vt) 
changes across nasal surface epithelial cells in vivo. The loss 
of CFTR-dependent anion conductance causes characteristic 
hyperpolarization, which is associated with a characteristic 
pattern of Vt changes in response to specific transport inhibi-
tors and agonists [7, 8]. Recently, US and European NPD 
protocols were published with new and better quantitative 
and discriminatory parameters for using the NPD as a bio-
marker of CFTR function [9, 10].
In this study, we measured the NPD to correlate the 
in vivo CFTR-chloride transport in the nasal epithelium 
with CF pulmonary function and airway bacterial coloniza-
tion. Secondarily, we analyzed the correlation with pancre-
atic phenotype, nutritional status, and genotype. Our results 
may help in further understanding of how abnormal anion 
transport is related to CF airway disease pathophysiology 
and help contribute to faster development of new and more 
effective treatments.
Methods
Study Subjects
CF patients in a clinically stable condition were  recruited 
from the pediatric and adult CF Clinics of Hospital de Clíni-
cas de Porto Alegre (HCPA) [1]. Subjects or their parents 
gave and signed a written informed consent. The study was 
reviewed and approved by the Ethical Review Board of 
HCPA and registered at HCPA Post-Graduation Research 
Group as number 05-125.
Data regarding age, sex and sweat chloride were collected 
from medical records. The pulmonary function was assessed 
as the percentage of predicted normal forced expiratory vol-
ume in one second  (ppFEV1) and as the  FEV1 z-score for 
age, sex and height for each individual subject measured 
by spirometry using the global lung function 2012 equation 
of the Global Lung Function Initiative [11]. Lung infection 
was defined as a single positive respiratory tract culture 
(throat, sputum, or bronchoalveolar lavage culture) within 
the previous six months for Pseudomonas aeruginosa (Pa) 
regardless of whether the subject cultured positive for other 
organisms. The pancreatic status (pancreatic insufficient (PI) 
or pancreatic sufficient (PS)) was evaluated based on need 
for pancreatic enzyme replacement therapy and/or on fecal 
elastase measurement. The nutritional status was assessed 
by the absolute body mass index (BMI) and BMI-for-age 
z-score. For patients older than 18 years of age, the BMI-for-
age z-score of 18-year-old subjects was used as a reference.
CFTR genotype data included analyzes by Real Time-
PCR of the 10 most frequent CFTR mutations in South 
Brazil (F508del, R347P, R347H, R334W, G542X, G551D, 
R553X, S549N, W1282X and N1303K) [12]. DNA sequenc-
ing was done in some patients if the PCR was negative. Each 
genotype was assigned to one of three groups according to 
the CFTR mutation, regardless of clinical features. The 
“severe” genotype group included patients with two muta-
tions of class I, II, or III; the “mild” genotype group included 
patients with at least one mutation of class IV, V or VI, 
and the “unknown” genotype group included patients with 
no identified CFTR mutation or without an available CFTR 
genetic test. The CFTR mutations were assigned to classes 
based on the list provided by Elborn [1] and completed 
according to the genotype severity.
Nasal Potential Difference
NPD measurements were performed as previously described 
using the dermal abrasion NPD-method [13] under stand-
ardized conditions. After direct rhinoscopy to assess nasal 
epithelium integrity, absence of polyps, and nasal turbinate 
anatomy the most stable voltage measure under the inferior 
nasal turbinate after basal solution perfusion was recorded as 
the maximum NPD (NPD-max). Other NPD measurements 
were recorded at the end of 3 sequential phases of perfu-
sion of each test solution as follows: (1) basal solution plus 
100 μM amiloride (2) low-chloride plus 100 μM amiloride 
solution, and (3) low-chloride plus 100 μM amiloride plus 
10 μM isoproterenol solution.
The following changes in NPD were recorded in response 
to: (1) amiloride (Δ-amil), which gives the response to 
blocking Na+ uptake through ENaC; (2) low-chloride plus 
amiloride solution (Δ-ØCl), which gives the Vt in response 
to a chloride gradient; (3) low-chloride plus amiloride plus 
isoproterenol solution (Δ-iso), which gives the Vt induced 
by isoproterenol via cAMP-mediated chloride conductance 
through CFTR. The sum of Δ-ØCl + Δ-iso was equivalent 
to the total chloride response (TCR). TCR was taken as the 
most sensitive and specific indicator of the CFTR-depend-
ent chloride conductance, and therefore, as the activity of 
CFTR-chloride channel [14].
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Statistical Analysis
Descriptive analyzes of categorical variables were presented 
as numerical and percentage (n (%)) values and of continu-
ous variables as mean ± standard deviation (SD). Correla-
tions were explored using Pearson’s rank correlation or Chi-
Square coefficient, as appropriate. Comparisons between 
groups were tested by the T-test, nonparametric Mann–Whit-
ney test or by ANOVA post-hoc multiple comparisons.
Analyzes were performed using SPSS 18.0 software. 
All P values were two-sided and considered significant if 
P < 0.05.
Results
The NPD was initially measured in 29 CF patients. One 
patient was excluded because the CF diagnosis was ques-
tioned. Another patient with a rare genotype (5 T–5 T) was 
retained because she demonstrates a classical phenotype 
including bronchiectasis, pancreatic insufficiency and sweat 
chloride > 60 mmol/L. The demographic data, the CFTR 
mutations, and NPD parameters of the CF patients are pre-
sented in Table 1. The NPD measurements according to pan-
creatic phenotype, Pseudomonas aeruginosa colonization, 
and genotype severity are presented in Table 2.
All patients demonstrated typical CF-NPD tracings with 
more negative NPD-max (− 35.14 ± 11.92  mV), raised 
Δ-amil (Δ-amil: 24.46 ± 10.38) and reduced TCR (TCR: 
− 1.82 ± 4.15) compared to our reference NPD parameters 
in normal controls (NPD-max − 15.00 ± 4.25 mV, Δ-amil: 
6.35 ± 3.5 and TCR: 11.82 ± 3.05). The TCR ranged from 
6 to − 10 mV and showed correlation with the age, being 
higher in older patients (r = 0.40; P = 0.03). No correlation 
was found between all NPD parameters and sweat chloride.
The TCR was also correlated with pulmonary phe-
notype. Better ppFEV1 and  FEV1−z score were signifi-
cantly correlated with a larger TCR (r = 0.48;  P = 0.01 
and  r = 0.49;  P < 0.01, respectively). However, after 
adjusting for age, the correlation between TCR and pul-
monary function approached the limit of significance 
(r = 0.38; P = 0.05), which may be due to the small sample 
size. CFTR function was apparently not associated with Pa 
colonization. But Pa colonization appeared to be associ-
ated with Δ-ØCl: A more negative Δ-ØCl (− 2.50 mV) was 
observed in Pa-negative patients compared to Pa-positive 
patients (Δ-ØCl = 0.56) (P < 0.05). Neither was CFTR func-
tion associated with pancreatic phenotype, since both PS and 
PI patients showed residual CFTR function. No association 
was found between TCR and nutritional status.
The TCR appeared to reflect genotype severity, being 
smallest in the severe genotype group (− 0.80 ± 3.80), 
intermediately reduced in the unknown genotype group 
(− 2.43 ± 4.89) and largest in the mild genotype group 
(− 3.67 ± 3.04). However, the differences between the groups 
did not attain statistical significance in this small population.
NPD-max and the Δ-amil were not correlated with pul-
monary function. Neither did they associate with airway 
Pa colonization. However, NPD-max appeared to reflect 
Table 1  Clinical data, genotype and NPD parameters of CF patients
Data are presented as mean ± standard deviation (range) or frequency 
(%).
mV millivolts, BMI body mass index, ppFEV1 forced expiratory vol-
ume in one second, NPD-max maximal nasal potential difference, 
Δamil response to amiloride, Δ-ØCl response to a chloride-free 
solution, containing amiloride, TCR total chloride response = sum 
of response to a chloride-free solution, containing amiloride 
(Δ-ØCl) + response to chloride-free solution containing amiloride and 
isoproterenol (Δ-iso)
Parameter Values
Age (years) 15.47 ± 6.09 (0.3–28)
Female 14 (50%)
Sweat chloride (mmol/L) 72.50 ± 14.39 (53–109)
Pancreatic insufficiency 21 (75%)
Pseudomonas aeruginosa positive 18 (64%)
BMI (kg/m2) 19.19 ± 3.27 (11.80–23.75)
BMI-for-age z-score − 0.45 ± 1.17 (− 3.65–1.00)
ppFEV1 80.00 ± 27.46 (28–133)
FEV1 z-score − 3.07 ± 1.17 (− 6.68–1.28)
CFTR genotype n (%)
 2 Mutations 21 (75)
 0 Mutation 4 (14)
 Not done 3 (11)
Mutations n (%)
 F508del/F508del 8 (29)
 F508del/1812-1G > A 2 (7)
 F508del/R1066H 2 (7)
 F508del/2789 + 5G > A 1 (3.6)
 F508del/3132delTG 1 (3.6)
 F508del/711 + 1G > T 1 (3.6)
 F508del/G542X 1 (3.6)
 F508del/p.Arg289AsnfsX17 1 (3.6)
 F508del/R1162X 1 (3.6)
 F508del/R334W 1 (3.6)
 5 T/5 T 1 (3.6)
 2307insA/R334W 1 (3.6)
Genotype severity n (%)
 Severe 15 (53.6)
 Mild 6 (21.4)
 Unknown 7 (25.0)
NPD-max (mV) − 35.14 ± 11.92 (− 76; − 19)
Δ-amil (mV) 24.46 ± 10.38 (9; 51)
Δ-ØCl (mV) − 0.54 ± 4.47 (− 7; 13)
TCR (mV) − 1.82 ± 4.15 (− 10; 6)
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pancreatic phenotype. A significantly more negative NPD-
max (− 38.57 ± 11.40 mV) (n = 21) was found in PI patients 
compared to PS patients (− 24.86 ± 4.19) (n = 7) (P < 0.01). 
No association was apparent between the pancreatic status 
and any other measured parameter (Table 2).
NPD-max was also correlated with genotype sever-
ity, being more negative in the severe genotype group 
(− 38.87 ± 13.92  mV), less negative in the mild geno-
type group (− 32.83 ± 7.41 mV) and least negative in the 
unknown genotype group (− 29.14 ± 7.14 mV). The dif-
ference was statistically significant between the severe and 
unknown group (P = 0.04) (Table 2).
Discussion
Our study showed that the in vivo CFTR-chloride transport 
in nasal epithelial cells in CF is correlated with better pul-
monary function and confirmed that it is also related to gen-
otype, representing a continuous spectrum associated with 
the genotype severity, appearing lower in patients with two 
severe CFTR mutations and higher in patients with milder 
genotype. Our study also showed that CFTR-chloride con-
ductance is strongly associated with pancreatic insufficiency. 
An interesting finding was the association between Pa with 
the cellular chloride diffusion through non-CFTR channels.
The cellular basis as well as the precise transport path-
ways of electrolyte and fluid, absorption and secretion, in 
the airways are still not well established nor are the primary 
mechanisms whereby defective CFTR leads to CF airway 
disease [2, 3, 15–18]. The normal airway epithelium appar-
ently consists of both absorptive and secretory cells whereby 
fluid and electrolyte transport are balanced across airway 
epithelia to regulate and maintain homeostasis of the ASL 
and support efficient MCC [17]. But maintenance of the 
alkaline ASL-pH based on bicarbonate secretion via CFTR 
or calcium-activated chloride channel-dependent (CaCCs) is 
also critical for normal MCC. In CF, the ASL is both more 
viscous as well as more acidic, impairing the airway MCC 
and causing mucus retention, airway inflammation, infec-
tion, and pulmonary destruction [3–5]. Our results indicate 
that residual CFTR-chloride conductance is associated with 
better pulmonary function. Unfortunately, we lack data to 
correlate CFTR-chloride conductance with structural lung 
damage, sputum rheology, or MCC measurements. Even 
though we only assessed the relative CFTR-chloride con-
ductance, it seems possible, if not likely, that the CFTR-
bicarbonate transport is affected or spared similarly, which 
would imply that increased residual CFTR-chloride conduct-
ance as well as increased residual CFTR-bicarbonate secre-
tion underlie better clinical outcomes in CF disease.
Pseudomonas aeruginosa is perhaps the most important 
pathogen in CF lung infection and often associated with 
more rapid decline in pulmonary function [1, 5]. We found 
no association between CFTR-chloride conductance with 
Pa. But, interestingly, we found an association between the 
magnitude of NPD response to the low-chloride plus ami-
loride solution-NPD (Δ-ØCl) with Pa infection. The Δ-ØCl 
represents the chloride diffusion that occurs because of a 
large chemical gradient generated by a chloride-free solu-
tion besides sodium conductance blocking caused by the 
amiloride. This chloride movement represents mainly the 
chloride conductance across alternative chloride channels, 
such as the CaCCs, which also transport bicarbonate [7–9], 
besides the chloride transport across CFTR. So, it could 
be possible that maintenance of chloride and bicarbonate 
transport across alternative channels is involved in bacterial 
airway clearance, mainly Pa. Of course, our small sample 
Table 2  NPD measurements 
according to pancreatic 
phenotype, Pseudomonas 
aeruginosa colonization and 
genotype severity
Data are presented as mean (± standard deviation)
NPD-max maximal nasal potential difference, Δ-amil response to amiloride, Δ-ØCl response to a chloride-
free solution, containing amiloride, TCR total chloride response = sum of response to a chloride-free solu-
tion, containing amiloride (Δ-ØCl) + response to chloride-free solution containing amiloride and isoproter-
enol (Δ-iso), PI pancreatic insufficient, PS pancreatic sufficient, Pa Pseudomonas aeruginosa.
**P < 0.01, *P < 0.05
NPD-max (mV) Δ-amil (mV) ΔØCl TCR (mV)
Pancreatic phenotype
 PI (n = 21) − 38.57 (11.40)** 25.71 (10.22) − 0.19 (4.73) − 1.57 (4.34)
 PS (n = 7) − 24.86 (4.19)** 20.71 (9.18) − 1.57 (2.97) − 2.57 (3.02)
Pseudomonas aeruginosa
 Pa+  (n = 18) − 36.94 (12.61) 25.89 (10.51) 0.56 (4.75)* − 1.78 (3.74)
 Pa− (n = 10) − 31.90 (9.02) 21.90 (9.06) − 2.50 (2.73)* − 1.90 (4.61)
Genotype
 Unknown (n = 7) − 29.14 (7.14)* 19.71 (9.97) 0.57 (5.68) − 2.43 (4.89)
 Mild (n = 6) − 32.83 (7.41) 28.00 (10.55) − 2.17 (4.14) − 3.67 (3.04)
 Severe (n = 15) − 38.87 (13.92)* 25.27 (10.07) − 0.40 (3.54) − 0.80 (3.80)
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size limits the significance of this finding, which has to be 
better studied. Others studies that analyzed the relationship 
between NPD and Pa infection did not find similar result 
[19–22], but a study by Green et al. described an association 
between residual CFTR function, predicted by the class of 
CFTR mutation, with delayed acquisition of multiple res-
piratory pathogens in CF, including Pseudomonas aerugi-
nosa [23]. In our study, however, no association was found 
between Pa and genotype severity.
The relationship between NPD and CFTR mutations has 
been reported for men with congenital bilateral absence of 
the vas deferens and subjects with non-cystic fibrosis bron-
chiectasis when used as a diagnostic approach [14, 20]. 
Wilschanski et al. [14] and Bienvenu et al. [24] reported that 
the NPD correlates with the number and the severity of the 
CFTR mutations in atypical CF cases. Our study confirmed 
that this relationship is also present in a within population 
of typical CF patients and that shows a pattern of continu-
ity based in genotype severity. The association was demon-
strated even though the genotype was unknown in 7 patients, 
a situation that is not unusual in CF because even extensive 
mutation analysis may fail to identify mutations in about 4% 
of patients having a conventional diagnosis of CF [1].
Pancreatic sufficiency is usually associated with better 
nutritional status and milder pulmonary disease in CF [1], 
but this association was not seen in our patients. Neither did 
we find a correlation between PS and residual CFTR-chlo-
ride conductance. Similarly, we did not find an association 
between nutritional condition and CFTR-chloride conduct-
ance. The association we found was between PS pancreatic 
sufficiency and lower cellular hyperpolarization (NPD-
max). Initially, the NPD-max was considered as a measure 
of the upregulated sodium absorption through ENaC that 
was not inhibited by lack of CFTR function in CF airways 
[7]. Recent studies in primary cultures of tracheal/bronchial 
CF epithelia did not confirm that the sodium absorption 
is increased in CF and the more negative NPD-max was 
attributed to the loss of anion transport [25]. Thus, the mag-
nitude of the NPD-max seems to be due essentially to the 
loss of anion conductance, chloride and bicarbonate, and 
not sodium hyperabsorption. So, based on these results, the 
defect in CFTR anion conductance is critical in determin-
ing pancreatic insufficiency, since bicarbonate is the major 
anion driving pancreatic duct fluid secretion [26]. Moreover, 
the pancreas is not known to absorb Na+ or express ENaC 
[26]. However, previous studies on NPD and CF pancreatic 
phenotype reported a correlation of residual CFTR function 
with pancreatic sufficiency [27, 28]. Nonetheless, our results 
may suffer from a lack of methods that yield a more quan-
titative evaluation of the pancreatic function in all patients, 
such as fecal elastase or the fecal fat measurements. Hence, 
minor malabsorption related to pancreatic insufficiency may 
not been diagnosed.
The limitations in this study include: (i) The small num-
ber of subjects limited solid comparisons between some 
groups, although sufficient sample size for correlation analy-
sis had been determined. (ii) We used the dermal abrasion 
NPD-method instead of the subcutaneous reference elec-
trode as suggested by ECFS–NPD–SOP or CFF–TDN–SOP 
guidelines [9, 10, 13]. We used a dermal abrasion because it 
was validated in our institution and because of the operator’s 
expertise. De Watcher et al. reported both methods are simi-
lar and acceptable suggesting that the operators preferred 
NPD-method should be used [29]. (iii) The final NPD step 
with an ATP-solution was not performed. ATP was not avail-
able in our laboratory, and we felt that this step is used more 
as a quality control to confirm the epithelial integrity rather 
than having essential diagnostic value.
In summary, in vivo less or no anion CFTR-conductance 
appears to be correlated with CF pulmonary and pancreatic 
disease. Thus, the CFTR function is the principal factor in 
CF airway disease pathogenesis and involves anions, chlo-
ride and bicarbonate. New therapeutics directed to correct 
the CFTR- anion conductance and/or the airway acidity are 
essential in CF, although further studies to elucidate the 
conductance of chloride and bicarbonate throughout CFTR 
or alternative channels like CaCCs are needed. Meanwhile, 
treatments directed to hydrate the airway and improve MCC 
or correct ASL-pH remain justified.
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